• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthofix Appoints New Spine Business Leader

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year

    Synaptive Medical's Modus V Expands Into Spine Market

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

    Micro Spine Implant Could Restore Standing and Walking

    RTI Surgical Appoints New Division Leaders

    From Nitinol to Nanotubes: A Materials Science Roundtable
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report

    Straightening Out a Spinal Device’s De Novo Pathway
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Atlas Vac Machine

    Tecomet

    Oberg Medical

    NN Life Sciences

    Donatelle
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    ISO 14971 Update: What Changes Can Medical Device Manufacturers Expect?

    ISO 14971 Update: What Changes Can Medical Device Manufacturers Expect?
    Related CONTENT
    • NASS News: Spineology Presents 12-Month Data for SCOUT Trial
    • RTI Surgical to Acquire Paradigm Spine
    • Simplify Medical Completes Enrollment in U.S. IDE Pivotal Trial of Simplify Disc
    • FDA Plans to Modernize 510(k) Program
    • Data Monitoring Committees: Making DMCs Work for Your Study
    Tony Parise, Product Strategist—Life Sciences, ETQ03.29.19
    ISO 14971 for medical device risk management is in the final stages of an important update slated for publication this year. While ISO has specifically said the intent of the revision isn’t to rework the risk management process, subtle changes in the latest version could impact medical device manufacturers in a variety of ways.

    The changes include a significant reorganization of content, new terms, and more detailed requirements around evaluating residual risks and collecting production and post-production information. It also refocuses the standard on benefit-risk evaluation, which is in line with changing regulatory requirements such as the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

    The revision is aimed mainly at clarification of the risk analysis process and the specific steps device manufacturers must take. Another goal was making it easier to update the standard’s guidance without going through the entire process of changing it.

    The joint working group (JWG) tasked with revising the standard achieved this by moving most of the guidance in ISO 14971 to Technical Report (TR) 24971, which is being revised in parallel. The new ISO 14971 has three informative annexes, with the other seven incorporated into TR 24971. The only annexes that would remain are rationale for requirements, risk management process, and fundamental risk concepts.

    The rest of the guidance has been moved to TR 24971, including recommendations on hazard identification, risk concepts and medical devices, risk analysis techniques, residual risk, risk management for in-vitro diagnostic devices, risk management for biological hazards, and risk management plan.

    This makes TR 24971, once a lesser-known document, an essential companion piece for ISO 14971 implementation. TR 24971’s guidance has expanded from 75 pages to over 100, providing detailed information on risk management tools, best practices, and useful examples.

    ISO 14971 defines a handful of new terms, including benefit (counterpart to the existing definition of risk) and state-of-the- art. One interesting addition is “reasonably foreseeable misuse,” defined as any improper use arising from “readily predictable human behavior,” according to the standard, and may or may not be intentional. This goes beyond user error, requiring manufacturers to consider a broader range of risks.

    For example, orthopedic manufacturers developing smart implants must consider the cybersecurity implications of connected devices in patients. Anything with embedded software must be robust and secure, where “reasonably foreseeable misuse” can result in high-impact risks. It’s why manufacturers incorporating IoT technology must prioritize risk management and should consider implementing (or at least following) ISO 14971 and companion standards.

    There are also changes to the standard’s requirements. Device manufacturers should pay special attention to language around benefit-risk analysis, residual risk, and production and post-production activities.

    ISO 14971:20XX strengthens language around benefit-risk analysis in the standard, reflecting a growing area of attention by regulatory bodies in evaluating compliance. The new TR 24971 expands guidance on determining benefits and criteria for benefit-risk analyses, providing specific examples of these types of decisions.

    Monitoring benefits is also important for post-production activities to determine whether the benefit-risk balance changes over time to adjust the risk management process accordingly. According to the new TR 24971, manufacturers should look for changes during post-production activities to inform benefit-risk analysis, including more/fewer patient benefits as revealed by clinical data; changes in medical practices; patient population changes; and introduction of new devices with different risks and benefits.

    ISO 14971 features a few small but important updates to the risk analysis process. Clause 5.4 focuses on hazard identification and now requires manufacturers to address reasonably foreseeable combinations of events that can create hazardous situations.

    Another key change is ISO 14971’s language around how to handle residual risks remaining after implementation of controls. The standard requires manufacturers to:
    • Describe the method for evaluating overall residual risk
    • Define criteria for acceptability of individual risks and overall residual risk
    • Perform a benefit-risk analysis on individual residual risks not meeting the criteria, as well as on the overall residual risk
    • Implement processes to continuously update risk management documentation, including with production and post-production data
    It’s important to note when evaluating residual risk, accepting too many small risks can constitute one big risk.

    ISO 14971 provides more detail on collecting production and post-production data, adding three new subclauses: Information Collection (10.1), Information Review (10.2), and Actions (10.3).

    The subclause on information collection requires companies to collect production and monitoring data; user-generated data; data originating from installation, use, and maintenance; supply chain data; and data related to the state-of-the-art, such as new standards, data, or alternative devices.

    The information review subclause relates to ongoing monitoring and requires manufacturers to consider the information they collect when the state-of-the-art changes.

    Standard Scope
    ISO 13485 for medical device quality management
    • More specific than ISO 9001
    • Refers to ISO 14971 as a recommended approach for complying with risk management requirements
    ISO 14971 for medical device risk management
    • Applies specifically to medical devices
    • Language based on ISO-IEC Guide 63 for medical device sector
    ISO 31000 for risk management
    • Focused on enterprise risk
    • Intended to help organizations protect business value and manage uncertainties in achieving governance, risk, and compliance (GRC) objectives
    • Language based on broader terms found in ISO-IEC Guide 73

    A new, important requirement under Actions (10.3) is manufacturers must take action on devices already on the market. For instance, if post-market surveillance uncovers a defective device, you may need to institute a recall, which wasn’t explicit in the previous version. These changes align with the existing FDA Quality System Regulation (QSR) and updated EU MDR requirements, part of a push toward globalizing product development regulations.

    The JWG also sought to clarify the difference between ISO 14971 and ISO 31000. As a result, they updated ISO 14971’s scope and will include a statement that it doesn’t apply to managing business risk. Companies now have more clarity when deciding whether to implement standards such as ISO 13485, ISO 14971, and ISO 31000. (See table)

    When ISO 14971 was last revised in 2007, the European Committee for Standardization released a European Normative (EN) version identifying gaps between the international standard and European regulations. EN ISO 14971:2012 highlights seven controversial deviations where regulators felt the standard fell short of the Medical Device Directive.

    ISO 14971:20XX should effectively address all but two of the seven deviations—benefit/risk analysis and risk control—in several cases by copying MDR language. As for unaddressed deviations, device manufacturers CE marking products must still:
    • Perform a benefit/risk analysis for all individual and residual risks (versus just those not meeting acceptability criteria per the ISO 14971 standard)
    • Implement risk controls for all individual risks (as compared to only those not meeting acceptability criteria)
    It’s unclear which of the original deviations were resolved until the European Commission publishes its update. Since several clauses were rewritten in alignment with EU MDR, hopefully there won’t be too much daylight between ISO 14971 and European regulations. There isn’t a new EN version of the standard in the works yet, so any clarity may be some time away.

    The new EU MDR and IVD regulations strongly emphasize risk management. While these regulations are clearly different from this latest version of ISO 14971, the standard’s architects clearly attempted to align it with EU regulations.

    Meanwhile, the FDA will adopt ISO 13485 for quality management as the basis for requirements to replace the existing QSR. ISO 13485 refers to ISO 14971 as a recommended approach to meeting ISO 13485’s requirements on risk management.

    All in all, it makes ISO 14971 an important standard for device manufacturers wanting to market products in both the EU and the U.S. An EN version of the standard is yet to come; the EU and potential Brexit impact still represent uncertainty.

    These updates add up, making it critical device manufacturers stay on top of the requirements. An effective quality management system (QMS) provides crucial support for complying with both standard and regulatory requirements, especially when the system is powered by automation.

    In place of unwieldy spreadsheets to manage ISO programs, many companies are moving quality and risk tracking processes to flexible, cloud-based platforms. This drives greater efficiency and visibility via applications with built-in best practices that help meet requirements. Core tools supporting compliance include risk register and risk analysis, document control, employee training, audit management, corrective action, centralized reporting and data analysis, and complaints management.

    ISO 14971 also adds a new subclause for normative references, changing the clause and subclause numbering from the 2007 to 20XX version (more details available in Annex B of the draft standard). It may not seem significant, but this will force companies to renumber many documents like training materials and quality procedures, as well as audit checklists, questions, and templates. Automation can also simplify this process.

    While the update seems like a raft of small changes, together it means a new, clearer direction for the standard and companies pursuing certification. The changes will leave a lasting impact and give manufacturers who invest in QMS automation a clear product quality and compliance competitive advantage. 


    Anthony Parise is a product strategist for life sciences at ETQ, a Burlington, Mass.-based leading provider of quality, EHS, and compliance management software trusted by some of the world’s strongest companies to secure brand reputation, transform insight into action, and help them focus on what matters most.
    Related Searches
    • compliance
    • implants
    • joint
    • FDA
    Suggested For You
    A Return to Memphis: An ODT Forum Preview A Return to Memphis: An ODT Forum Preview
    FDA Commissioner Scott Gottlieb to Step Down FDA Commissioner Scott Gottlieb to Step Down
    FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients
    Realizing the Promise of Pre-Validated Packaging Realizing the Promise of Pre-Validated Packaging
    Squeaky Clean: Orthopedic Device Packaging & Sterilization Squeaky Clean: Orthopedic Device Packaging & Sterilization
    2019: The Year to Enhance Quality in Orthopedic Product Development 2019: The Year to Enhance Quality in Orthopedic Product Development
    FDA Approves Orthofix FDA Approves Orthofix's M6-C Artificial Cervical Disc for Cervical Disc Degeneration Treatment
    EPTAM Acquires Relius Medical EPTAM Acquires Relius Medical
    Nanowire-Coated Electrodes Could Rewire an Injured Spinal Cord Nanowire-Coated Electrodes Could Rewire an Injured Spinal Cord
    BioPoly Granted European Patent for its Implant Design BioPoly Granted European Patent for its Implant Design
    FDA OKs Additive Orthopaedics FDA OKs Additive Orthopaedics' Patient-Specific 3D Printed Locking Lattice Plates
     MEDICREA Achieves 3,000 Surgery Milestone with UNiD ASI and Patient-Specific Implants MEDICREA Achieves 3,000 Surgery Milestone with UNiD ASI and Patient-Specific Implants
    Treace Medical Enrolls First Patient in ALIGN3D Post-Market Clinical Study Treace Medical Enrolls First Patient in ALIGN3D Post-Market Clinical Study
    Sounding Board: 2018 Reflections and Looking Ahead Sounding Board: 2018 Reflections and Looking Ahead
    Material Matters: New Offerings for Orthopedic Technologies Material Matters: New Offerings for Orthopedic Technologies

    Related Columns

    • Extremities
      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Dr. Carl Hasselman, co-designer of the Arthrosurface ToeMotion Arthroplasty System, speaks about non-fusion alternatives for MTPJ osteoarthritis.
      Michael Barbella, Managing Editor 12.02.19

    • The Cluster Effect in Orthopedics: Is It Sustainable?

      The Cluster Effect in Orthopedics: Is It Sustainable?

      For a long time, we all assumed Minnesota dominated the medical device industry worldwide, but is this true for the orthopedic surgical tools industry?
      Maria Shepherd, President and Founder, Medi-Vantage 12.02.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 12.02.19


    • Turning the New EU MDR Into a Competitive Advantage

      Turning the New EU MDR Into a Competitive Advantage

      This column examines three new elements of the EU MDR that medical device manufacturers can leverage.
      Dan Goldstein, Associate Director, Quality Assurance, MCRA LLC 12.02.19

    • Design | Large Joint | Spine/Neurology
      Five Reasons for the Small World of Orthopedic Product Development

      Five Reasons for the Small World of Orthopedic Product Development

      Why do product development people tend to stay within the orthopedic and spine industry and not cross over into other medtech sectors?
      Victoria Trafka, BSME, MSME, President and Lead Engineer, Engineering & Quality Solutions Inc. 12.02.19

    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff, and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 12.02.19


    • Spine/Neurology
      Pediatric Orthopedics Taken Off the Back Burner

      Pediatric Orthopedics Taken Off the Back Burner

      There are several different types of scoliosis, a condition that causes a sideways spinal curve, that affect children and adolescents.
      Sam Brusco, Associate Editor 09.17.19

    • What Are Orthopedic Surgeon Salary and Employment Statistics?

      What Are Orthopedic Surgeon Salary and Employment Statistics?

      The percent of employed physicians is greater than self-employed physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 09.17.19

    • U.S. May Offer a Safe Harbor from the Impending MDR Storm

      U.S. May Offer a Safe Harbor from the Impending MDR Storm

      There are factors that make for a more inviting environment for the medical device industry in the United States.
      Dawn A. Lissy, President & Founder, Empirical 09.17.19


    • How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      As of 2017, the European medical device market was estimated  at $126 billion, the second largest worldwide, comprising 27 percent of the global market. The European market trails only the United States, which accounts for roughly 43 percent of…
      Mike Goodson, Associate Director, Regulatory Affairs, MCRA LLC 09.17.19

    • Software & Quality
      Benefiting from Paperless Production Records: A Case Study

      Benefiting from Paperless Production Records: A Case Study

      EpiBone discovered how eliminating paper with digital production records can help ensure data integrity, reduce errors, and increase efficiency.
      Terrance Holbrook, Director of Product, MasterControl 09.17.19

    • Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      ODT Staff 08.14.19

    • What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      With the continued surge of mergers and acquisitions, vertical integrations, and no clear U.S. policy or reform direction for our $3.6 trillion annual healthcare spend,1 the healthcare ecosystem remains in a phase of dramatic disruption. What Is K…
      Maria Shepherd, President and Founder, Medi-Vantage 08.14.19

    • Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal. Despite this s…
      Dawn A. Lissy, President & Founder, Empirical 08.14.19

    • Successful Strategies for Health Plan Medical Policy Outreach

      Successful Strategies for Health Plan Medical Policy Outreach

      Getting approval from the FDA can be a significant achievement for a company but a bigger challenge awaits for novel technologies: health payor acceptance and coverage. Adopting a novel technology does not occur easily due to complex commercial insur…
      Chelsey Jaworski and Anabel Tapia, MCRA 08.14.19


    Breaking News
    • Orthofix Appoints New Spine Business Leader
    • Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    • Synaptive Medical's Modus V Expands Into Spine Market
    • 3D-Printed Graftless Bone Transplants Go to Clinical Trials
    • CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Awarded $1M BMGF Grant
    Vivera Pharma, Parexel Ink Clinical Services Agreement
    MedPharm Triples Capacity at RTP Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WWP Wins Three NJPEC Awards
    Cat-Themed Beauty Collection to Launch in Japan
    Pantone Names Classic Blue the 2020 Color of the Year
    Happi

    Latest Breaking News From Happi

    Lip Lab Opening in Brooklyn
    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.